Pflug Koory, LLC Gilead Sciences, Inc. Transaction History

Pflug Koory, LLC

$1.4 Billion
Q1 2024

A detailed history of Pflug Koory, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pflug Koory, LLC holds 2,020 shares of GILD stock, worth $185,597. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,020

Previous 2,025 0.25%

Holding current value

$185,597

Previous $164,000 10.37%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$71.58 - $87.29 $357 - $436	-5 Reduced 0.25%	2,020 $147,000
Q1 2023 Apr 20, 2023	SELL	$77.31 - $88.08 $7,731 - $8,808	-100 Reduced 4.71%	2,025 $168,000
Q4 2022 Jan 18, 2023	SELL	$62.32 - $89.47 $5,920 - $8,499	-95 Reduced 4.28%	2,125 $182,000
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $5,772 - $6,501	-100 Reduced 4.31%	2,220 $137,000
Q1 2022 Apr 14, 2022	SELL	$57.92 - $72.58 $21,720 - $27,217	-375 Reduced 13.91%	2,320 $138,000
Q3 2021 Oct 19, 2021	SELL	$67.69 - $73.03 $33,845 - $36,515	-500 Reduced 15.65%	2,695 $188,000
Q2 2021 Jul 14, 2021	BUY	$63.47 - $69.35 $31,735 - $34,675	500 Added 18.55%	3,195 $220,000
Q1 2021 Jul 13, 2021	SELL	$60.0 - $68.46 $38,280 - $43,677	-638 Reduced 19.14%	2,695 $174,000
Q4 2020 Jan 14, 2021	SELL	$56.65 - $64.55 $27,758 - $31,629	-490 Reduced 12.82%	3,333 $194,000
Q3 2020 Oct 20, 2020	BUY	$62.1 - $78.08 $15,525 - $19,520	250 Added 7.0%	3,823 $242,000
Q4 2019 Jan 14, 2020	BUY	$61.62 - $67.78 $1,540 - $1,694	25 Added 0.7%	3,573 $232,000
Q3 2019 Oct 15, 2019	BUY	$62.51 - $69.0 $4,063 - $4,485	65 Added 1.87%	3,548 $225,000
Q2 2019 Aug 02, 2019	SELL	$61.87 - $69.38 $16,086 - $18,038	-260 Reduced 6.95%	3,483 $235,000
Q1 2019 Apr 11, 2019	SELL	$62.53 - $70.05 $7,816 - $8,756	-125 Reduced 3.23%	3,743 $243,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $75,675 - $98,750	-1,250 Reduced 24.42%	3,868 $242,000
Q3 2018 Nov 06, 2018	SELL	$71.28 - $78.92 $19,958 - $22,097	-280 Reduced 5.19%	5,118 $395,000
Q1 2018 Aug 13, 2018	SELL	$72.84 - $88.8 $7,284 - $8,880	-100 Reduced 1.82%	5,398 $407,000
Q3 2017 Aug 13, 2018	BUY	$72.11 - $85.47 $10,816 - $12,820	150 Added 2.8%	5,498 $445,000
Q2 2017 Aug 13, 2018	BUY	N/A	415 Added 8.41%	5,348 $379,000
Q1 2017 Aug 13, 2018	BUY	N/A	875 Added 21.56%	4,933 $335,000
Q4 2016 Aug 13, 2018	BUY	N/A	4,058	4,058 $291,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pflug Koory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pflug Koory, LLC with notifications on news.

Account